Accessibility Menu
 
Creative Medical Technology logo

Creative Medical Technology

(NASDAQ) CELZ

Current Price$2.07
Market Cap$7.59M
Since IPO (2016)-100%
5 YearN/A
1 Year-4%
1 Month+15%

Creative Medical Technology Financials at a Glance

Market Cap

$7.59M

Revenue (TTM)

$6.00K

Net Income (TTM)

$6.00M

EPS (TTM)

$-2.29

P/E Ratio

-0.89

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$2.07

Volume

40

Open

$2.09

Previous Close

$2.07

Daily Range

$2.07 - $2.09

52-Week Range

$1.50 - $6.25

CELZ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Creative Medical Technology

Industry

Biotechnology

Employees

4

CEO

Timothy Warbington

Headquarters

Phoenix, AZ 85012, US

CELZ Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1024%

Net Income Margin

-999%

Return on Equity

-87%

Return on Capital

-82%

Return on Assets

-77%

Earnings Yield

-1.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.59M

Shares Outstanding

3.70M

Volume

40

Short Interest

0.00%

Avg. Volume

63.60K

Financials (TTM)

Gross Profit

$119.52K

Operating Income

$6.14M

EBITDA

$6.02M

Operating Cash Flow

$5.86M

Capital Expenditure

$5.00

Free Cash Flow

$5.86M

Cash & ST Invst.

$7.21M

Total Debt

$0.00

Creative Medical Technology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.00K

+0.0%

Gross Profit

$28.94K

-1707.9%

Gross Margin

-9.65%

N/A

Market Cap

$7.59M

N/A

Market Cap/Employee

$1.90M

N/A

Employees

4

N/A

Net Income

$1.89M

-1.8%

EBITDA

$1.98M

-1.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.21M

+21.3%

Accounts Receivable

$52.08K

N/A

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-76.77%

N/A

Return on Invested Capital

-81.64%

N/A

Free Cash Flow

$1.94M

+0.6%

Operating Cash Flow

$1.94M

+0.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KPRXKiora Pharmaceuticals, Inc.
$1.94-0.51%
BCDABioCardia, Inc.
$1.20+3.45%
ACXPAcurx Pharmaceuticals, Inc.
$3.68-5.40%
APREAprea Therapeutics, Inc.
$0.72+1.65%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%
NOKNokia
$8.82+0.07%

Questions About CELZ

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.